Table 3

Chronological changes of treatment for central serous chorioretinopathy

YearIncidence*Not treatedTreatedTreated
PDTLaser photocoagulationAnti-VEGF
Cases (%)Cases (%)CasesCasesCases
201128 07525 667 (91.42)2408 (8.58)4581423531
201229 40726 113 (88.80)3294 (11.20)5352136632
201327 83124 327 (87.41)3504 (12.59)5172070925
201426 77623 182 (86.61)3594 (13.39)56019761060
201526 66822 867 (85.75)3801 (14.25)57420401195
201624 33220 653 (84.88)3679 (15.12)56918261301
201718 42214 704 (79.82)3718 (20.18)62217231384
Total181 501157 513 (86.78)23 988 (13.22)383513 1947028
  • The duration from onset to the initial treatment (±SD) was 110.0±94.8 days, 60.0±82.2 days and 96.0±92.4 days for PDT, laser photocoagulation and anti-VEGF, respectively.

  • *Incidence of central serous chorioretinopathy with at least 1 year of follow-up.

  • PDT, photodynamic therapy; Anti-VEGF, anti-vascular endothelial growth factor